Federated Hermes, Inc. Tandem Diabetes Care Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $23.2 Million - $36.7 Million	-653,104 Reduced 98.46%	10,236 $460,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $20.9 Million - $33 Million	-477,772 Reduced 41.87%	663,340 $31.7 Million
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $3.17 Million - $7.32 Million	-59,482 Reduced 4.95%	1,141,112 $67.5 Million
Q1 2022 May 13, 2022	BUY	$101.89 - $150.09 $90,682 - $133,580	890 Added 0.07%	1,200,594 $140 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $4.84 Million - $6.28 Million	40,966 Added 3.54%	1,199,704 $181 Million
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $10.8 Million - $14.9 Million	-115,090 Reduced 9.03%	1,158,738 $138 Million
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $2,156 - $2,805	28 Added 0.0%	1,273,828 $124 Million
Q1 2021 May 13, 2021	SELL	$81.28 - $104.34 $10,160 - $13,042	-125 Reduced 0.01%	1,273,800 $112 Million
Q4 2020 Feb 12, 2021	SELL	$86.4 - $121.75 $2.66 Million - $3.75 Million	-30,809 Reduced 2.36%	1,273,925 $122 Million
Q3 2020 Nov 12, 2020	SELL	$95.43 - $116.09 $4.26 Million - $5.18 Million	-44,598 Reduced 3.31%	1,304,734 $148 Million
Q2 2020 Aug 13, 2020	SELL	$60.05 - $98.92 $4.66 Million - $7.67 Million	-77,569 Reduced 5.44%	1,349,332 $133 Million
Q1 2020 May 13, 2020	SELL	$47.37 - $90.04 $1.49 Million - $2.83 Million	-31,440 Reduced 2.16%	1,426,901 $91.8 Million
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $2.97 Million - $3.99 Million	-55,992 Reduced 3.7%	1,458,341 $86.9 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $1.51 Million - $1.94 Million	-26,482 Reduced 1.72%	1,514,333 $89.3 Million
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $3.28 Million - $4.32 Million	-60,262 Reduced 3.76%	1,540,815 $99.4 Million
Q1 2019 May 10, 2019	SELL	$32.25 - $73.56 $3.51 Million - $8.01 Million	-108,955 Reduced 6.37%	1,601,077 $102 Million
Q4 2018 Feb 13, 2019	BUY	$28.45 - $40.65 $2.89 Million - $4.13 Million	101,631 Added 6.32%	1,710,032 $64.9 Million
Q3 2018 Nov 13, 2018	SELL	$21.39 - $51.17 $22.4 Million - $53.6 Million	-1,048,099 Reduced 39.45%	1,608,401 $68.9 Million
Q2 2018 Aug 10, 2018	BUY	$4.9 - $23.64 $1.99 Million - $9.6 Million	406,224 Added 18.05%	2,656,500 $58.5 Million
Q1 2018 May 09, 2018	BUY	$2.35 - $4.96 $5.29 Million - $11.2 Million	2,249,961 Added 714273.31%	2,250,276 $11.2 Million
Q4 2017 Feb 28, 2018	BUY	$2.24 - $8.2 $705 - $2,583	315	315 $1,000

Others Institutions Holding TNDM

# of Institutions

352

Shares Held

73M

Call Options Held

3.36M

Put Options Held

229K

Black Rock Inc. New York, NY

11.1M
Shares

$412 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.36M
Shares

$273 Million
0.01% of portfolio
Capital World Investors Los Angeles, CA

3.27M
Shares

$121 Million
0.02% of portfolio
State Street Corp Boston, MA

2.66M
Shares

$98.4 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

2.39M
Shares

$88.5 Million
1.44% of portfolio

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account